This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Market Squall Making Me Seasick

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Investors worried about the short-term direction of stocks beware, Jim Cramer warned his Mad Money viewers Monday. Today's squall could last for a few days longer.

How could everything that was loved last week be hated this week? The move has a lot less to do with actual earnings and a lot more to do with how the big portfolio managers view the world. Until today, the markets loved health care, with stocks like UnitedHealth Group (UNH) offering excellent earnings, growth and a wholly domestic story. But today shares fell by 2%.

Must Read: 10 Stocks Carl Icahn Is Buying

Meanwhile, Freeport McMoRan (FCX), which has seen disappointing earnings and roaring debts, was able to rally by 5%.

It turns out money managers are changing their world view, betting on increased inflation. That's good news for commodity stocks like Freeport but bad news for health care, which typically gets sold during that part of the economic cycle. That's also how an oil driller like Helmerich & Payne (HP) can catch an analyst upgrade, as it did today. Analysts are betting on a bottom for oil.

This trend continues with stocks like Celgene (CELG) falling 3% despite positive drug trial news, and Apple (AAPL), a stock Cramer owns for his charitable trust, Action Alerts PLUS, not signaling a clear direction despite blockbuster results.

Off the Tape

In his "Off the Tape" segment, Cramer sat down with Elizabeth Holmes, founder and CEO of the privately held diagnostics firm Theranos as well as the youngest self-made female billionaire in the U.S.

Holmes explained that Theranos' technology allows patients to receive medical tests with just a few drops of blood from a finger prick rather than from drawing multiple vials of blood as is done today.

The system, now in a trial program at 40 Walgreens Boots (WBA) locations, makes it far more affordable and convenient for patients to get the tests they need, thereby empowering them with the clinical information that drives nearly 80% of medical decisions.

While the entrenched laboratory testing industry is less than enthused by the simpler and far less intrusive technology, Cramer said he's betting patients around the world would embrace it with open arms.

Must Read: How to Trade an Apple Dividend Increase

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BMRN $116.97 -2.75%
INTC $32.50 1.31%
RH $91.62 -0.29%
AAPL $132.65 1.82%
FB $81.91 0.47%


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs